ddp4 and glp 1 Frontiers The effect of DPP-4 inhibitors,

Classified as a cosmetic/cosmeceutical ingredient, it has less strong independent clinical trial data than retinoids/peptides

Not as magic pills that will solve everything, but as support that makes other positive changes more achievable

Now, fibromyalgia is making a potential appearance on this management list, according to a Medscape article Reporting on a large-scale health records analysis, the article states The use of GLP-1 receptor agonists was linked to lower pain and fatigue in patients with fibromyalgia The way that I use it in my practice these days is that if I have a patient with chronic pain or with fibromyalgia who has comorbidities that already have an FDA approval for GLP-1 use, such as obesity, diabetes, or obstructive sleep apnea, I would encourage them to go to their primary care physician and maybe consider getting started on a GLP-1, said presenter Nouran Eshak, MB ChB, of the Mayo Clinic in Scottsdale, Arizona. However, the article also lists several limitations to the study including Researchers were unable to account for confounders such as duration of illness, symptom severity, GLP-1 dosage, or access to healthcare. Disclaimer: This post is not a recommendation, rather just a report

The same dose of any compound produces different blood levels in different people

Glutamine synthesis and hydrolysis is mainly mediated by glutamine synthetase (GS) and phosphate -dependent glutaminase (GLS)

NOT expanded access